Bharat Biotech on Monday utilized for emergency use authorisation for its indigenously developed COVID-19 vaccine ‘Covaxin’ to Medicine Controller Basic of India (DCGI), officers mentioned. Bharat Biotech is the third firm which has utilized for emergency use authorisation for its vaccine. It’s the second Indian firm to use for emergency use authorisation after the Serum Institute of India utilized for such use for a vaccine developed by Oxford College and AstraZeneca. Pfizer had utilized for the emergency use authorisation to DCGI on December 6.
More Stories
Smartphone market down simply 4% in 2020 on increased demand in second half of the 12 months
Scarcity of syringes challenges plans to get an additional dose of vaccine out of vial
Dixon Applied sciences arm inks take care of HMD India for manufacturing Nokia smartphones